Lysosomal Storage Diseases Market - Global Outlook and Forecast 2022-2028

March 2022 | 64 pages | ID: L9E5DB7222F3EN
Market Monitor Global

Abstracts

Lysosomal storage diseases (LSDs) refer to a group of diseases arising because of the deficiency of lysosomal enzymes, which leads to the accumulation of partially digested or undigested macromolecules inside the cell.

This report contains market size and forecasts of Lysosomal Storage Diseases in Global, including the following market information:

Global Lysosomal Storage Diseases Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Lysosomal Storage Diseases market was valued at 7651.9 million in 2021 and is projected to reach US$ 10550 million by 2028, at a CAGR of 4.7% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Enzyme Replacement Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Lysosomal Storage Diseases include Actelion Pharmaceuticals, BioMarin, Genzyme, Takeda, Alexion Pharmaceuticals, Amicus Therapeutics, Chiesi Farmaceutici, Greenovation Biotech And FGK Clinical Research and Horizon Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Lysosomal Storage Diseases companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Lysosomal Storage Diseases Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Lysosomal Storage Diseases Market Segment Percentages, by Type, 2021 (%)

• Enzyme Replacement Therapy
• Substrate Reduction Therapy
• Cystine Depleting Agents

Global Lysosomal Storage Diseases Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Lysosomal Storage Diseases Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Ambulatory Surgical Centers

Global Lysosomal Storage Diseases Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Lysosomal Storage Diseases Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Lysosomal Storage Diseases revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Lysosomal Storage Diseases revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Actelion Pharmaceuticals
• BioMarin
• Genzyme
• Takeda
• Alexion Pharmaceuticals
• Amicus Therapeutics
• Chiesi Farmaceutici
• Greenovation Biotech And FGK Clinical Research
• Horizon Pharma
• Leadiant Biosciences
• Mylan

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Lysosomal Storage Diseases Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Lysosomal Storage Diseases Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL LYSOSOMAL STORAGE DISEASES OVERALL MARKET SIZE

2.1 Global Lysosomal Storage Diseases Market Size: 2021 VS 2028
2.2 Global Lysosomal Storage Diseases Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Lysosomal Storage Diseases Players in Global Market
3.2 Top Global Lysosomal Storage Diseases Companies Ranked by Revenue
3.3 Global Lysosomal Storage Diseases Revenue by Companies
3.4 Top 3 and Top 5 Lysosomal Storage Diseases Companies in Global Market, by Revenue in 2021
3.5 Global Companies Lysosomal Storage Diseases Product Type
3.6 Tier 1, Tier 2 and Tier 3 Lysosomal Storage Diseases Players in Global Market
  3.6.1 List of Global Tier 1 Lysosomal Storage Diseases Companies
  3.6.2 List of Global Tier 2 and Tier 3 Lysosomal Storage Diseases Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Lysosomal Storage Diseases Market Size Markets, 2021 & 2028
  4.1.2 Enzyme Replacement Therapy
  4.1.3 Substrate Reduction Therapy
  4.1.4 Cystine Depleting Agents
4.2 By Type - Global Lysosomal Storage Diseases Revenue & Forecasts
  4.2.1 By Type - Global Lysosomal Storage Diseases Revenue, 2017-2022
  4.2.2 By Type - Global Lysosomal Storage Diseases Revenue, 2023-2028
  4.2.3 By Type - Global Lysosomal Storage Diseases Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Lysosomal Storage Diseases Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Ambulatory Surgical Centers
5.2 By Application - Global Lysosomal Storage Diseases Revenue & Forecasts
  5.2.1 By Application - Global Lysosomal Storage Diseases Revenue, 2017-2022
  5.2.2 By Application - Global Lysosomal Storage Diseases Revenue, 2023-2028
  5.2.3 By Application - Global Lysosomal Storage Diseases Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Lysosomal Storage Diseases Market Size, 2021 & 2028
6.2 By Region - Global Lysosomal Storage Diseases Revenue & Forecasts
  6.2.1 By Region - Global Lysosomal Storage Diseases Revenue, 2017-2022
  6.2.2 By Region - Global Lysosomal Storage Diseases Revenue, 2023-2028
  6.2.3 By Region - Global Lysosomal Storage Diseases Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Lysosomal Storage Diseases Revenue, 2017-2028
  6.3.2 US Lysosomal Storage Diseases Market Size, 2017-2028
  6.3.3 Canada Lysosomal Storage Diseases Market Size, 2017-2028
  6.3.4 Mexico Lysosomal Storage Diseases Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Lysosomal Storage Diseases Revenue, 2017-2028
  6.4.2 Germany Lysosomal Storage Diseases Market Size, 2017-2028
  6.4.3 France Lysosomal Storage Diseases Market Size, 2017-2028
  6.4.4 U.K. Lysosomal Storage Diseases Market Size, 2017-2028
  6.4.5 Italy Lysosomal Storage Diseases Market Size, 2017-2028
  6.4.6 Russia Lysosomal Storage Diseases Market Size, 2017-2028
  6.4.7 Nordic Countries Lysosomal Storage Diseases Market Size, 2017-2028
  6.4.8 Benelux Lysosomal Storage Diseases Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Lysosomal Storage Diseases Revenue, 2017-2028
  6.5.2 China Lysosomal Storage Diseases Market Size, 2017-2028
  6.5.3 Japan Lysosomal Storage Diseases Market Size, 2017-2028
  6.5.4 South Korea Lysosomal Storage Diseases Market Size, 2017-2028
  6.5.5 Southeast Asia Lysosomal Storage Diseases Market Size, 2017-2028
  6.5.6 India Lysosomal Storage Diseases Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Lysosomal Storage Diseases Revenue, 2017-2028
  6.6.2 Brazil Lysosomal Storage Diseases Market Size, 2017-2028
  6.6.3 Argentina Lysosomal Storage Diseases Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Lysosomal Storage Diseases Revenue, 2017-2028
  6.7.2 Turkey Lysosomal Storage Diseases Market Size, 2017-2028
  6.7.3 Israel Lysosomal Storage Diseases Market Size, 2017-2028
  6.7.4 Saudi Arabia Lysosomal Storage Diseases Market Size, 2017-2028
  6.7.5 UAE Lysosomal Storage Diseases Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Actelion Pharmaceuticals
  7.1.1 Actelion Pharmaceuticals Corporate Summary
  7.1.2 Actelion Pharmaceuticals Business Overview
  7.1.3 Actelion Pharmaceuticals Lysosomal Storage Diseases Major Product Offerings
  7.1.4 Actelion Pharmaceuticals Lysosomal Storage Diseases Revenue in Global Market (2017-2022)
  7.1.5 Actelion Pharmaceuticals Key News
7.2 BioMarin
  7.2.1 BioMarin Corporate Summary
  7.2.2 BioMarin Business Overview
  7.2.3 BioMarin Lysosomal Storage Diseases Major Product Offerings
  7.2.4 BioMarin Lysosomal Storage Diseases Revenue in Global Market (2017-2022)
  7.2.5 BioMarin Key News
7.3 Genzyme
  7.3.1 Genzyme Corporate Summary
  7.3.2 Genzyme Business Overview
  7.3.3 Genzyme Lysosomal Storage Diseases Major Product Offerings
  7.3.4 Genzyme Lysosomal Storage Diseases Revenue in Global Market (2017-2022)
  7.3.5 Genzyme Key News
7.4 Takeda
  7.4.1 Takeda Corporate Summary
  7.4.2 Takeda Business Overview
  7.4.3 Takeda Lysosomal Storage Diseases Major Product Offerings
  7.4.4 Takeda Lysosomal Storage Diseases Revenue in Global Market (2017-2022)
  7.4.5 Takeda Key News
7.5 Alexion Pharmaceuticals
  7.5.1 Alexion Pharmaceuticals Corporate Summary
  7.5.2 Alexion Pharmaceuticals Business Overview
  7.5.3 Alexion Pharmaceuticals Lysosomal Storage Diseases Major Product Offerings
  7.5.4 Alexion Pharmaceuticals Lysosomal Storage Diseases Revenue in Global Market (2017-2022)
  7.5.5 Alexion Pharmaceuticals Key News
7.6 Amicus Therapeutics
  7.6.1 Amicus Therapeutics Corporate Summary
  7.6.2 Amicus Therapeutics Business Overview
  7.6.3 Amicus Therapeutics Lysosomal Storage Diseases Major Product Offerings
  7.6.4 Amicus Therapeutics Lysosomal Storage Diseases Revenue in Global Market (2017-2022)
  7.6.5 Amicus Therapeutics Key News
7.7 Chiesi Farmaceutici
  7.7.1 Chiesi Farmaceutici Corporate Summary
  7.7.2 Chiesi Farmaceutici Business Overview
  7.7.3 Chiesi Farmaceutici Lysosomal Storage Diseases Major Product Offerings
  7.7.4 Chiesi Farmaceutici Lysosomal Storage Diseases Revenue in Global Market (2017-2022)
  7.7.5 Chiesi Farmaceutici Key News
7.8 Greenovation Biotech And FGK Clinical Research
  7.8.1 Greenovation Biotech And FGK Clinical Research Corporate Summary
  7.8.2 Greenovation Biotech And FGK Clinical Research Business Overview
  7.8.3 Greenovation Biotech And FGK Clinical Research Lysosomal Storage Diseases Major Product Offerings
  7.8.4 Greenovation Biotech And FGK Clinical Research Lysosomal Storage Diseases Revenue in Global Market (2017-2022)
  7.8.5 Greenovation Biotech And FGK Clinical Research Key News
7.9 Horizon Pharma
  7.9.1 Horizon Pharma Corporate Summary
  7.9.2 Horizon Pharma Business Overview
  7.9.3 Horizon Pharma Lysosomal Storage Diseases Major Product Offerings
  7.9.4 Horizon Pharma Lysosomal Storage Diseases Revenue in Global Market (2017-2022)
  7.9.5 Horizon Pharma Key News
7.10 Leadiant Biosciences
  7.10.1 Leadiant Biosciences Corporate Summary
  7.10.2 Leadiant Biosciences Business Overview
  7.10.3 Leadiant Biosciences Lysosomal Storage Diseases Major Product Offerings
  7.10.4 Leadiant Biosciences Lysosomal Storage Diseases Revenue in Global Market (2017-2022)
  7.10.5 Leadiant Biosciences Key News
7.11 Mylan
  7.11.1 Mylan Corporate Summary
  7.11.2 Mylan Business Overview
  7.11.3 Mylan Lysosomal Storage Diseases Major Product Offerings
  7.11.4 Mylan Lysosomal Storage Diseases Revenue in Global Market (2017-2022)
  7.11.5 Mylan Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Lysosomal Storage Diseases Market Opportunities & Trends in Global Market
Table 2. Lysosomal Storage Diseases Market Drivers in Global Market
Table 3. Lysosomal Storage Diseases Market Restraints in Global Market
Table 4. Key Players of Lysosomal Storage Diseases in Global Market
Table 5. Top Lysosomal Storage Diseases Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Lysosomal Storage Diseases Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Lysosomal Storage Diseases Revenue Share by Companies, 2017-2022
Table 8. Global Companies Lysosomal Storage Diseases Product Type
Table 9. List of Global Tier 1 Lysosomal Storage Diseases Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Lysosomal Storage Diseases Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Lysosomal Storage Diseases Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Lysosomal Storage Diseases Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Lysosomal Storage Diseases Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Lysosomal Storage Diseases Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Lysosomal Storage Diseases Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Lysosomal Storage Diseases Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Lysosomal Storage Diseases Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Lysosomal Storage Diseases Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Lysosomal Storage Diseases Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Lysosomal Storage Diseases Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Lysosomal Storage Diseases Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Lysosomal Storage Diseases Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Lysosomal Storage Diseases Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Lysosomal Storage Diseases Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Lysosomal Storage Diseases Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Lysosomal Storage Diseases Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Lysosomal Storage Diseases Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Lysosomal Storage Diseases Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Lysosomal Storage Diseases Revenue, (US$, Mn), 2023-2028
Table 30. Actelion Pharmaceuticals Corporate Summary
Table 31. Actelion Pharmaceuticals Lysosomal Storage Diseases Product Offerings
Table 32. Actelion Pharmaceuticals Lysosomal Storage Diseases Revenue (US$, Mn), (2017-2022)
Table 33. BioMarin Corporate Summary
Table 34. BioMarin Lysosomal Storage Diseases Product Offerings
Table 35. BioMarin Lysosomal Storage Diseases Revenue (US$, Mn), (2017-2022)
Table 36. Genzyme Corporate Summary
Table 37. Genzyme Lysosomal Storage Diseases Product Offerings
Table 38. Genzyme Lysosomal Storage Diseases Revenue (US$, Mn), (2017-2022)
Table 39. Takeda Corporate Summary
Table 40. Takeda Lysosomal Storage Diseases Product Offerings
Table 41. Takeda Lysosomal Storage Diseases Revenue (US$, Mn), (2017-2022)
Table 42. Alexion Pharmaceuticals Corporate Summary
Table 43. Alexion Pharmaceuticals Lysosomal Storage Diseases Product Offerings
Table 44. Alexion Pharmaceuticals Lysosomal Storage Diseases Revenue (US$, Mn), (2017-2022)
Table 45. Amicus Therapeutics Corporate Summary
Table 46. Amicus Therapeutics Lysosomal Storage Diseases Product Offerings
Table 47. Amicus Therapeutics Lysosomal Storage Diseases Revenue (US$, Mn), (2017-2022)
Table 48. Chiesi Farmaceutici Corporate Summary
Table 49. Chiesi Farmaceutici Lysosomal Storage Diseases Product Offerings
Table 50. Chiesi Farmaceutici Lysosomal Storage Diseases Revenue (US$, Mn), (2017-2022)
Table 51. Greenovation Biotech And FGK Clinical Research Corporate Summary
Table 52. Greenovation Biotech And FGK Clinical Research Lysosomal Storage Diseases Product Offerings
Table 53. Greenovation Biotech And FGK Clinical Research Lysosomal Storage Diseases Revenue (US$, Mn), (2017-2022)
Table 54. Horizon Pharma Corporate Summary
Table 55. Horizon Pharma Lysosomal Storage Diseases Product Offerings
Table 56. Horizon Pharma Lysosomal Storage Diseases Revenue (US$, Mn), (2017-2022)
Table 57. Leadiant Biosciences Corporate Summary
Table 58. Leadiant Biosciences Lysosomal Storage Diseases Product Offerings
Table 59. Leadiant Biosciences Lysosomal Storage Diseases Revenue (US$, Mn), (2017-2022)
Table 60. Mylan Corporate Summary
Table 61. Mylan Lysosomal Storage Diseases Product Offerings
Table 62. Mylan Lysosomal Storage Diseases Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Lysosomal Storage Diseases Segment by Type in 2021
Figure 2. Lysosomal Storage Diseases Segment by Application in 2021
Figure 3. Global Lysosomal Storage Diseases Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Lysosomal Storage Diseases Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Lysosomal Storage Diseases Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Lysosomal Storage Diseases Revenue in 2021
Figure 8. By Type - Global Lysosomal Storage Diseases Revenue Market Share, 2017-2028
Figure 9. By Application - Global Lysosomal Storage Diseases Revenue Market Share, 2017-2028
Figure 10. By Region - Global Lysosomal Storage Diseases Revenue Market Share, 2017-2028
Figure 11. By Country - North America Lysosomal Storage Diseases Revenue Market Share, 2017-2028
Figure 12. US Lysosomal Storage Diseases Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Lysosomal Storage Diseases Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Lysosomal Storage Diseases Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Lysosomal Storage Diseases Revenue Market Share, 2017-2028
Figure 16. Germany Lysosomal Storage Diseases Revenue, (US$, Mn), 2017-2028
Figure 17. France Lysosomal Storage Diseases Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Lysosomal Storage Diseases Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Lysosomal Storage Diseases Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Lysosomal Storage Diseases Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Lysosomal Storage Diseases Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Lysosomal Storage Diseases Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Lysosomal Storage Diseases Revenue Market Share, 2017-2028
Figure 24. China Lysosomal Storage Diseases Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Lysosomal Storage Diseases Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Lysosomal Storage Diseases Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Lysosomal Storage Diseases Revenue, (US$, Mn), 2017-2028
Figure 28. India Lysosomal Storage Diseases Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Lysosomal Storage Diseases Revenue Market Share, 2017-2028
Figure 30. Brazil Lysosomal Storage Diseases Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Lysosomal Storage Diseases Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Lysosomal Storage Diseases Revenue Market Share, 2017-2028
Figure 33. Turkey Lysosomal Storage Diseases Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Lysosomal Storage Diseases Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Lysosomal Storage Diseases Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Lysosomal Storage Diseases Revenue, (US$, Mn), 2017-2028
Figure 37. Actelion Pharmaceuticals Lysosomal Storage Diseases Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. BioMarin Lysosomal Storage Diseases Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Genzyme Lysosomal Storage Diseases Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Takeda Lysosomal Storage Diseases Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Alexion Pharmaceuticals Lysosomal Storage Diseases Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Amicus Therapeutics Lysosomal Storage Diseases Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Chiesi Farmaceutici Lysosomal Storage Diseases Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Greenovation Biotech And FGK Clinical Research Lysosomal Storage Diseases Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Horizon Pharma Lysosomal Storage Diseases Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Leadiant Biosciences Lysosomal Storage Diseases Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Mylan Lysosomal Storage Diseases Revenue Year Over Year Growth (US$, Mn) & (2017-2022)